EULAR Corporate Members
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
|UCB BioPharma SRL|
|Janssen Pharmaceutica NV|
|Novartis Pharma AG|
|Eli Lilly and Company|
|AstraZeneca UK Ltd.|
|GlaxoSmithKline Research and Development Ltd.|
|Boehringer Ingelheim International GmbH|
|Amgen (Europe) GmbH|
|F. Hoffmann-La Roche Ltd.|
|Vifor Fresenius Medical Care Renal Pharma Ltd.|
|IBSA Institut Biochimique SA|
|Fresenius Kabi SwissBioSim|
|Celltrion Healthcare Co. Ltd.|
|Otsuka Pharmaceutical Europe Ltd.|
|Biogen International GmbH|
|Merck Healthcare KGaA|
Gilead Sciences Europe Ltd.
Swedish Orphan Biovitrum AB
The EULAR Family
A presentation of the EULAR member organisations.
EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.